News & Views
Heart drug could treat respiratory failure
Sep 23 2011
According to findings published in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine, the calcium-sensitising drug levosimendan could be effective in improving muscle function in patients with respiratory muscle weakness.
Dr Leo Heunks, a pulmonary and critical care physician at Radboud University Nijmegen Medical Centre in the Netherlands, explained that levosimendan improved the efficiency of the diaphragm, which suggests it may improve muscle function in those with respiratory failure.
The drugs are effective because muscles need calcium in order to contract and calcium sensitisers improve the muscles' ability to contract.
"Respiratory muscle weakness frequently occurs in patients with chronic diseases, and also in critically ill patients on the ventilator, making breathing more difficult and causing more severe illness and even death," Dr Heunks explained.
"To date, there is no specific drug treatment available to improve respiratory muscle function in patients with respiratory muscle failure."
Digital Edition
International Labmate Buyers' Guide 2024/25
June 2024
Buyers' Guide featuring: Product Listings & Manufacturers Directory Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters - Digital transformatio...
View all digital editions
Events
Jul 07 2024 Dublin, Ireland
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia